Glp-1 deagues don't give the key deses to weight loss

The UVA reveals that the famous GLP -1 drugs help people to leave several pounds, but drugs fail to provide a major improvement in heart and lung function.

Popular GLP-1 drugs can help most people lose weight, but drugs fail to provide a major improvement in the functioning of the heart and Lung piercing, Virginia University experts warn in new paper.

Researchers confirm that losses associated with improving obesity, there are advantages and development of assistance.

"Some patients told me they lose muscles or muscles, says Virginian Medical School, James M.M." This is a serious problem. "Muscles, especially elderrial muscles, because the loss of body mass, these drugs are not enough to make a mold or low muscle mass. "

Um glp-1 lyf

Although GLP-1 drugs help people lose fat, this comes with loss of fat-free mass, from which the muscles make up 40% to 50%.In fact, lost mass-free mass represents 25-40% of the lost pounds, while the age-free decrease is only 8% per decade.

Liu and his partner, graduate and graduate, Siddera, Siddear professional and Siddears, Siddler's Drugs Professional and Tribal Pharmacists.

Exercise, lungs and deaths is CRF (or VO2MAX) to use oxygen when it comes to lung and death.

Most obesity patients have a low CRF.In the case, due to the lack of muscle mass.In others, the human muscle is sufficient, but this muscle is sufficient in the quality of the muscle.

The heart-word, Unauty Hard Cions of UNAI, Ladio, saying:CRF has been high enough for the crisis of the crisis or the risk of the fatigue.

In an overview of available medical literature, researchers found that GLP-1 drugs could improve certain cardiac function measures, but these improvements did not result in significant improvement in Vo2max.

Some small studies have noted that training can help improve Vo2max in patients taking GLP-1, but they need bad and larger and planned research.

To ensure a healthy weight

The researchers ultimately concludes that GLP-1 medicines "without clear evidence of thick improvement without ffm."They are worried that it can affect the metabolic health of patients, health / obligations and general longevity.The best possible results.

However, they declare that monoclonal partner is found in a monoclonal partner, that may occur that can occur with that.

"It is an area of active research, and we said," Loe said, "Anufing" recommends that the darkness remember to reserve the backups to reserve the backs.

"Finally," said Angadi: "Training must be trained during GLP1 treatment with its VO2Maxit GLP1 ability to maintain or improve during treatment."

Research has met with its own in JCIM, the clinic and mitabulman played periogely, Rumboilial Prognance, R0114344 andR01D1230.5130.51330.5135.513000.5130.5130.51330.5135.5135.5135.513.51330.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.5135.513.

Uva investigators have no economic interest in work.

Subscribe to the issue of medical blogs to continue the latest news of medical research from UVA.